
Making news in neuroscience accessible and digestible for the public. Breaking down promising research articles for those living with neurodegenerative diseases like Alzheimer's and Parkinson's - Every Saturday Morning
| Platform | Pricing | Freemium | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 40 | Founded | a year ago | Last Issue | 7 days ago |
| Active | |||||

A major milestone in Parkinson’s Disease (PD) drug research has been reached, which further reduces motor symptoms in PD patients compared to conventional medications. A once-daily oral pill reduced irritating symptoms (tremors, unstable po...
Alzheimer’s Disease (AD) is not going anywhere. With over 7 million Americans and 50+ million globally diagnosed with AD, and numbers expected to grow exponentially, it is worth knowing how the disease functions and deteriorates the brain a...
Just ~30 years ago, medical professionals and scientists believed that the brain had no immune activity. The blood-brain barrier prevents peripheral immune cells from entering the brain and spinal cord, so researchers assumed these two syst...
Approximately 10-20% of Parkinson’s disease (PD) patients have tremor-dependent PD, and many others have other motor complications called dyskinesias. Recent advancements in focused ultrasound offer medication-resistant patients significant...
Stanford scientists claim big implications for "the power house of the cell" in neurodegeneration
Ah yes… The infamous mitochondria, the powerhouse of the cell. Stanford scientists believe that regulating a specific pathway within this ene...
Subscribers, engagement, traffic and sponsorship for Neuro For All.
| Subscribers | Engagement | 69 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Making news in neuroscience accessible and digestible for the public. NeuroForAll breaks down complex neuroscience topics and brings forth promising research articles to those living with neurological conditions and their loved ones.
đź§ BSc pharmacology student with a love for neuroscience! brain research simplified
You can find recent issues that have been published by Neuro For All on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Neuro For All, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Neuro For All as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Neuro For All using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Neuro For All. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.